{
    "clinical_study": {
        "@rank": "74014", 
        "brief_summary": {
            "textblock": "Recent data has demonstrated that focal sources are determinant in human atrial fibrillation\n      (AF) perpetuation.\n\n      The investigators sought to identify crucial areas for AF perpetuation during our routine\n      electrogram (EGM)-based substrate ablation."
        }, 
        "brief_title": "Crucial Areas on AF Termination", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Atrial Fibrilation Termination Endpoint", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Atrial Fibrilation\n\n          -  Undergoing EGM-based substrate ablation\n\n        Exclusion Criteria:\n\n          -  Age < 18"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients with symptomatic Atrial Fibrilation  undergoing EGM-based substrate ablation were\n        included."
            }
        }, 
        "enrollment": {
            "#text": "113", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02099643", 
            "org_study_id": "HSJ-2013-03"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 28, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13008"
                    }, 
                    "name": "Hopital Saint Joseph"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Massy", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Priv\u00e9 Jacques Cartier;"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Institut Mutualiste Montsouris;"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London;", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Morphology Unit Royal Brompton Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Crucial Areas on Atrial Fibrillation Termination by Substrate Ablation: Relevance to Anatomy", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Conseil National de l'Ordre des M\u00e9decins", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "conversion to atrial tachycardia (AT) or sinus rhythm", 
            "measure": "Atria fibrillation termination during procedure", 
            "safety_issue": "No", 
            "time_frame": "240 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02099643"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital St. Joseph, Marseille, France", 
            "investigator_full_name": "SEITZ JULIEN", 
            "investigator_title": "CARDIOLOGIST", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Crucial points were defined by areas where ablation immediately extended the cycle length> 20% of AF CL, or regularized Atrial Fibrilation (AF) into Atrial Tachycardia (AT) or converted AF (or AT) into Sinus Rythm", 
            "measure": "Crucial points", 
            "safety_issue": "No", 
            "time_frame": "240 min"
        }, 
        "source": "Hospital St. Joseph, Marseille, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital St. Joseph, Marseille, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2008", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "5 Days", 
        "verification_date": "March 2014"
    }
}